These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33283733)

  • 61. [Somatic Mutations of Acquired Aplastic Anemia].
    Zhang ML; Chen WS; Han B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):491-496. PubMed ID: 35791949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database.
    Enrico A; Bestach Y; Flores MG; Arbelbide J; Serale C; Novoa V; Crisp R; Rivas MM; Larripa I; Belli C
    Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):743-752.e5. PubMed ID: 28797621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
    Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
    Tiacci E; Grossmann V; Martelli MP; Kohlmann A; Haferlach T; Falini B
    Haematologica; 2012 Jan; 97(1):3-5. PubMed ID: 22210327
    [No Abstract]   [Full Text] [Related]  

  • 65. Myelodysplastic syndromes: Contemporary review and how we treat.
    Gangat N; Patnaik MM; Tefferi A
    Am J Hematol; 2016 Jan; 91(1):76-89. PubMed ID: 26769228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients.
    Ball S; Aguirre LE; Jain AG; Ali NA; Tinsley SM; Chan O; Kuykendall AT; Sweet K; Lancet JE; Sallman DA; Hussaini MO; Padron E; Komrokji RS
    Leuk Res; 2023 Jan; 124():106999. PubMed ID: 36542963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Analysis of ASXL1 gene variant in patients with myelodysplastic syndrome].
    Chen M; Liu J; Chao H; Qin W; Jiang N; Lu X; Cen L; Jiang Y; Cai X; Zhang R; Wang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):110-115. PubMed ID: 32034733
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes.
    Xiong B; Nie Y; Tang Z; Xue M; Zuo X
    Pathology; 2017 Aug; 49(5):526-533. PubMed ID: 28669578
    [TBL] [Abstract][Full Text] [Related]  

  • 70. U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Qian W; Wang CZ; Chai HY; Yang J; Li Y; Deng ZQ; Ma JC; Chen XX
    PLoS One; 2012; 7(9):e45760. PubMed ID: 23029227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic Markers of Myelodysplastic Syndromes.
    Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Zhimulev IF
    Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32727068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.
    Loghavi S; Al-Ibraheemi A; Zuo Z; Garcia-Manero G; Yabe M; Wang SA; Kantarjian HM; Yin CC; Miranda RN; Luthra R; Medeiros LJ; Bueso-Ramos CE; Khoury JD
    Br J Haematol; 2015 Oct; 171(1):91-9. PubMed ID: 26123119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic value of
    Liang S; Zhou X; Pan H; Yang Y; Shi L; Wang L
    Hematology; 2019 Dec; 24(1):613-622. PubMed ID: 31482762
    [No Abstract]   [Full Text] [Related]  

  • 74. Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies.
    Drevon L; Marceau A; Maarek O; Cuccuini W; Clappier E; Eclache V; Cluzeau T; Richez V; Berkaoui I; Dimicoli-Salazar S; Bidet A; Vial JP; Park S; Vieira Dos Santos C; Kaphan E; Berthon C; Stamatoullas A; Delhommeau F; Abermil N; Braun T; Sapena R; Lusina D; Renneville A; Adès L; Raynaud S; Fenaux P
    Br J Haematol; 2018 Sep; 182(6):843-850. PubMed ID: 30004110
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.
    Xu F; Jin J; Guo J; Xu F; Chen J; Liu Q; Song L; Zhang Z; Zhou L; Su J; Xiao C; Zhang Y; Yan M; He Q; Wu D; Chang C; Li X; Wu L
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):71. PubMed ID: 38305890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.
    Bally C; Adès L; Renneville A; Sebert M; Eclache V; Preudhomme C; Mozziconacci MJ; de The H; Lehmann-Che J; Fenaux P
    Leuk Res; 2014 Jul; 38(7):751-5. PubMed ID: 24836762
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
    Jhanwar SC
    Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome.
    Jiang G; Capo-Chichi JM; Liu A; Atenafu EG; Guo R; Tierens A; Minden MD; Chang H
    Hum Pathol; 2020 Oct; 104():117-126. PubMed ID: 32798550
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of
    Li B; Zou D; Yang S; Ouyang G; Mu Q
    J Int Med Res; 2020 Mar; 48(3):300060519891013. PubMed ID: 31826693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
    Papageorgiou SG; Vasilatou D; Kontos CK; Kotsianidis I; Symeonidis A; Galanopoulos AG; Hatzimichael E; Megalakaki A; Poulakidas E; Diamantopoulos P; Vassilakopoulos TP; Zikos P; Papadaki H; Mparmparousi D; Bouronikou E; Panayiotidis P; Viniou NA; Pappa V
    Am J Hematol; 2018 Jul; 93(7):895-901. PubMed ID: 29659040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.